Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Clinical Study Evaluating the Safety and Performance of Eurosilicone Integrated Valve Tissue Expanders (IVTE)

NCT: NCT07842406 · NOT_YET_RECRUITING

NCT IDNCT07842406
StatusNOT_YET_RECRUITING
Start Date2026-10
Completion2027-10
SponsorGCA (Eurosilicone) (INDUSTRY)
First posted
Last updated

Brief Summary

Patients can undergo breast reconstruction surgery in two stages before implantation of the permanent prosthesis for several reasons. In order to confidently state safety and due to strict regulation on medical devices it is important to maintain a record of safety and performance with all medical implants. This study is designed to collect data on Integrated valve tissue expander to assess the performance and safety data on this device.

Frequently Asked Questions

What is A Clinical Study Evaluating the Safety and Performance of Eurosilicone Integrated Valve Tissue Expanders (IVTE)?

A Clinical Study Evaluating the Safety and Performance of Eurosilicone Integrated Valve Tissue Expanders (IVTE) is a clinical trial registered under NCT07842406. Current status: NOT_YET_RECRUITING.

What is the status of NCT07842406?

The current status of NCT07842406 (A Clinical Study Evaluating the Safety and Performance of Eurosilicone Integrated Valve Tissue Expanders (IVTE)) is: NOT_YET_RECRUITING.

When did A Clinical Study Evaluating the Safety and Performance of Eurosilicone Integrated Valve Tissue Expanders (IVTE) start?

A Clinical Study Evaluating the Safety and Performance of Eurosilicone Integrated Valve Tissue Expanders (IVTE) started on 2026-10.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑